Alpha Anomeric is Drug Discovery in France that focus on developer business. Founded in 2018. They cover business area such as developer, genetic medicine, new RNA target, proprietary alpha anomeric-bicyclo dna platform, unprecedented precision, RNA modulation, common side effect, current oligonucleotide chemistry, effectiveness, treatment, physician, patient, severe neuromuscular disease.
2018
( 6 years old in 2024 )
Developer
-
140 Bis, Rue de Rennes
75006 Paris
France
Private
developergenetic medicinenew RNA targetproprietary alpha anomeric-bicyclo dna platformunprecedented precisionRNA modulationcommon side effectcurrent oligonucleotide chemistryeffectivenesstreatmentphysicianpatientsevere neuromuscular disease
* We use standard office opening hours in near Alpha Anomeric's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alpha Anomeric is Drug Discovery business from France that founded in 2018 (6 years old in 2024), Alpha Anomeric business is focusing on Developer.
Alpha Anomeric headquarter office and corporate office address is located in 140 Bis, Rue de Rennes 75006 Paris France.
Alpha Anomeric was founded in France.
In 2024, Alpha Anomeric is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alpha Anomeric, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
